AstraZeneca $27B wipeout as Wainua late trial misses cardiovascular target
A failed late-stage heart study triggered a swift market punishment, forcing investors and boards to reset timelines and risk.

Loading the Newsroom
Curating from trusted global sources…
65 briefings · “billion”
A failed late-stage heart study triggered a swift market punishment, forcing investors and boards to reset timelines and risk.
The chip giant filed for a Nasdaq listing plan that could raise $29.4 billion, instantly reshaping investor expectations.
The satellite and rocket company’s quick $25 billion borrowing move signals how it plans to finance scale after going public.
Big IPO, bigger options debut: what it means for investors, risk teams, and anyone benchmarking market appetite.
SpaceX exercised its option for Cursor in an all-stock deal worth $60 billion, reshaping AI dealmaking expectations.
Lovable, Replit, and others are raising billions as Big Tech both bets on and panics about AI-built software.
The Aussie mining billionaire just put Hancock Prospecting behind Musk's rocket-and-satellite combo, and markets noticed.
What looks like a simple streaming bet is actually a $22 billion corporate reshuffle with board and regulatory gravity.
Billions Club era hits a new peak: Spotify and Amazon cite top single-day and 24-hour global debuts after June 12.
SpaceX shares jumped, and Musk’s $800B pre-IPO value crossed a trillion, reshaping how investors price “moonshots.”
The SpaceX IPO values the company around $1.77T and estimates Musk’s stake at $866.5B, with broad investor ripple effects.
The SPCX listing breaks records, but Japanese household investors quietly took a meaningful chunk of the biggest payday ever.